NZpharma SRL
The score of NZpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +746 % Total assets +286 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
NZpharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Sep 2026
- Year ended 31 Dec 2024filed on 29 Sep 2025
- Year ended 31 Dec 2023filed on 31 Dec 2024
NZpharma's financial analysis
- Solvency87.6%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of NZpharma
NZpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1002.404.928
- VAT number
- BE1002404928
- Peppol
- Registered · 0208:1002404928 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Nov 2023
- Registered office
- 1200 Woluwe-Saint-Lambert
- Latest accounts
- 2025 · filed on 10 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
NZpharma (SRL) has been based in Woluwe-Saint-Lambert since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 23,881 € and equity of 65,000 €; its revenue is not published. Its solvency stands at 87.6%, above the median of its sector (37.8%).
Companies similar to NZpharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Parent Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 304,281 €
- L.V. Farma Retail sale of pharmaceutical products Hasselt · balance sheet 83,799 €
- TAM Pharma Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 63,040 €
- MB Pharmaceutics Retail sale of pharmaceutical products Riemst · balance sheet 57,363 €
- Apego Retail sale of pharmaceutical products Geel · balance sheet 89,749 €
- Manon De Marez Retail sale of pharmaceutical products Herent · balance sheet 85,130 €
- Apotheker Laura Spiritus Retail sale of pharmaceutical products Linter · balance sheet 62,639 €
- FarmaST Retail sale of pharmaceutical products Zonhoven · balance sheet 107,177 €
Frequently asked questions about NZpharma
What is the revenue of NZpharma?
NZpharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of NZpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1002404928 for NZpharma, if the company is VAT-registered. Its company number (CBE) is 1002.404.928.
Where is the registered office of NZpharma?
According to the CBE register, the registered office of NZpharma is in 1200 Woluwe-Saint-Lambert.
What is the equity of NZpharma?
At the close of the 2025 financial year, the equity of NZpharma amounts to 65,000 €, a solvency of 87.6% of total assets.
Who manages NZpharma?
The register lists 2 active mandates at NZpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of NZpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →